LumiraDx Limited Common Shares is a diagnostics & research business based in the US. LumiraDx Limited Common Shares shares (LMDX) are listed on the NASDAQ and all prices are listed in US Dollars. LumiraDx Limited Common Shares employs 1,500 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $10.00 |
|---|---|
| 52-week range | $7.15 - $11.09 |
| 50-day moving average | $9.20 |
| 200-day moving average | $9.51 |
| Wall St. target price | $14.94 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-2.22 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $10 from 2022-01-21
| 1 week (2022-01-14) | 6.27% |
|---|---|
| 1 month (2021-12-23) | 11.23% |
| 3 months (2021-10-22) | 16.82% |
| 6 months (2021-07-23) | 1.11% |
| 1 year (2021-01-19) | N/A |
|---|---|
| 2 years (2020-01-19) | N/A |
| 3 years (2019-01-19) | N/A |
| 5 years (2017-01-19) | N/A |
| Revenue TTM | $415.4 million |
|---|---|
| Gross profit TTM | $52.9 million |
| Return on assets TTM | -12.27% |
| Return on equity TTM | 0% |
| Profit margin | -44.15% |
| Book value | $1.36 |
| Market capitalisation | $2.4 billion |
TTM: trailing 12 months
We're not expecting LumiraDx Limited Common Shares to pay a dividend over the next 12 months.
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom. .
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.